LT - INHIBITORS OF MET, VEGFR AND RET FOR USE IN THE TREATMENT OF LUNG ADENOCARCINOMA
EN - INHIBITORS OF MET, VEGFR AND RET FOR USE IN THE TREATMENT OF LUNG ADENOCARCINOMA
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/47 |
|
|
|
A61P 35/00 |
|
European patent
| (11) |
Number of the document |
2892532 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
13765886.0 |
|
Date of filing the European patent application |
2013-09-09 |
| (97) |
Date of publication of the European application |
2015-07-15 |
| (45) |
Date of publication and mention of the grant of the patent |
2019-02-13
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/US2013/058768 |
|
Date |
2013-09-09 |
PCT application publication
| (87) |
Number |
WO 2014/039971 |
|
Date |
2014-03-13 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201261698143 P |
2012-09-07
|
US |
Inventors
| (72) |
AFTAB, Dana, T., US
|
Grantee
| (73) |
Exelixis, Inc.,
1851 Harbor Bay Parkway, Alameda, CA 94502,
US
|
Title
| (54) |
INHIBITORS OF MET, VEGFR AND RET FOR USE IN THE TREATMENT OF LUNG ADENOCARCINOMA |
| |
INHIBITORS OF MET, VEGFR AND RET FOR USE IN THE TREATMENT OF LUNG ADENOCARCINOMA |
